BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16144933)

  • 21. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
    Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
    Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.
    Hunter MG; Druhan LJ; Massullo PR; Avalos BR
    Am J Hematol; 2003 Nov; 74(3):149-55. PubMed ID: 14587040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases.
    Hellström-Lindberg E; Schmidt-Mende J; Forsblom AM; Christensson B; Fadeel B; Zhivotovsky B
    Br J Haematol; 2001 Mar; 112(3):714-26. PubMed ID: 11260077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells: relevance to the pathogenesis of myelodysplastic syndrome.
    Awaya N; Uchida H; Miyakawa Y; Kinjo K; Matsushita H; Nakajima H; Ikeda Y; Kizaki M
    J Cell Physiol; 2002 Jun; 191(3):327-35. PubMed ID: 12012328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sequential treatment with granulocyte-colony stimulating factor (GCSF) and human recombinant erythropoietin (rH-EPO) in anemia of a patient with myelodysplastic syndrome and high blood transfusion requirements)].
    Borbolla-Escoboza JR; González-Avante CM; López-Hernández MA; Flores-Chapa JD; Collados-Larumbe MT
    Gac Med Mex; 1997; 133(4):355-9. PubMed ID: 9410796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo.
    Robinson Y; Matenov A; Tschöke SK; Weimann A; Oberholzer A; Ertel W; Hostmann A
    Acta Anaesthesiol Scand; 2008 May; 52(5):605-13. PubMed ID: 18419713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies.
    Catalano L; Selleri C; Califano C; Luciano L; Volpicelli M; Rocco S; Varriale G; Ricci P; Rotoli B
    Haematologica; 2000 Feb; 85(2):133-8. PubMed ID: 10681719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
    Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
    Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
    Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
    Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA.
    Arimura K; Arima N; Matsushita K; Ohtsubo H; Fujiwara H; Kukita T; Ozaki A; Hagiwara T; Hamada H; Yoshino K; Tei C
    Eur J Haematol; 2004 Jul; 73(1):17-24. PubMed ID: 15182333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
    Tsuzuki M; Okamoto M; Yamaguchi T; Ino T; Ezaki K; Hirano M
    Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
    Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
    Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.
    Sastre JL; Ulibarrena C; Bustillo M; Suárez-Gago M; García-Torremocha MS; Vázquez MO
    Haematologica; 1998 Aug; 83(8):763-5. PubMed ID: 9793271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythroid precursor cells in primary acquired and secondary sideroblastic anemia.
    Takaku F; Mizoguchi H; Suda T; Kubota K; Miura Y
    Exp Hematol; 1980; 8 Suppl 8():225-34. PubMed ID: 6962069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T) with superimposed 5q-syndrome.
    Ziarkiewicz M; Dwilewicz-Trojaczek J; Pastwińska A; Chmarzyńska E; Paszkowska-Kowalewska M; Koperski Ł; Jędrzejczak WW; Ziarkiewicz-Wróblewska B
    Pol J Pathol; 2010; 61(2):105-9. PubMed ID: 20924996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasia.
    Bowen D; Hyslop A; Keenan N; Groves M; Culligan D; Johnson P; Shaw A; Geddes F; Evans P; Porter J; Cavill I
    Haematologica; 2006 May; 91(5):709-10. PubMed ID: 16670077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased apoptosis in acquired sideroblastic anaemia.
    Matthes TW; Meyer G; Samii K; Beris P
    Br J Haematol; 2000 Dec; 111(3):843-52. PubMed ID: 11122146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of hematopoietic growth factors on extensive apoptosis of myelodysplastic hematopoietic cells and its clinical significance].
    Cao Z; Li R; Li Q
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):27-30. PubMed ID: 10921099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients.
    Nakao K; Wada J; Ota K; Ichikawa H; Akagi S; Okamoto A; Hida K; Nagake Y; Makino H
    Am J Kidney Dis; 2003 Mar; 41(3):624-36. PubMed ID: 12612986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
    Sarycheva TG; Tsvetaeva NV; Kozinets GI
    Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.